Journal of Developing Drugs
Open Access
ISSN: 2329-6631
+44 1478 350008
ISSN: 2329-6631
+44 1478 350008
Kamran Atif
Scientific Tracks Abstracts: J Dev Drugs
The aim of this study is to evaluate Quality Excellence for GMP Compliance at Pharmaceuticals that can be achieved easily through integration of various GMP requirements integration (ICH Pharmaceutical Development-Q8,Quality Risk Management-Q9 &Pharmaceutical Quality System-Q10)with quality improvement models that includes Malcolm Balridge National Quality Awards in Unites States of America, European Quality Award Model, Deming Price in Japan, Six Sigma & ISO 9001 (Quality Management System). Pursuing to these models & its outcomes in the organization across the globe for improving quality, productivity & optimization of operations. Role of quality models & cGMP is considered as foundation of quality culture ins Pharmaceuticals and reflect robust Quality Management System. These models and GMP principles of various regulatory authority has impressive results in organizations with stable research work over past few decades & focus also included patient safety, drug quality, leadership, team work, supplier development, management reviews& customer focus.
Kamran Atif is a Pharmaceutical Chemist with additional degree in Total Quality Management in Medicines & doing PhD research on Operational Excellence in Pharmaceuticals, also IRCA-UK QMS lead auditor with direct working experience of (+12) years in Quality Management, Quality Assurance & Technical Operations with emphasis on implementation of USFDA, WHO & European Medicines Agency (EMEA) Regulations. He also worked professionally for some of the renowned pharmaceuticals & written different Pharmaceutical articles in leading magazines. He also presented various talks in the Middle East, Europe & USA on cGMP, Drug Delivery & Benchmarking in Pharmaceuticals Operations. Currently he is working at Arwan Pharmaceutical Industries Lebanon.